Alopecia Areata in a Patient with Candidiasis-Endocrinopathy Syndrome: Unsuccessful Treatment Trial with Diphenylcyclopropenone

    January 1995 in “ Dermatology
    Roland Böni, R M Trüeb, B Wüthrich
    TLDR The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.
    The document reported a case of candidiasis-endocrinopathy syndrome (CES) associated with alopecia areata, characterized by chronic mucocutaneous candidiasis and endocrine dysfunction. Histological examination of the scalp showed minor inflammation, significant hair follicle atrophy, and sclerotic whorls near the hair papillae. A treatment trial using diphenylcyclopropenone was unsuccessful, likely due to the long-standing nature of alopecia areata and the patient's immune deficiency. Additionally, the patient had agenesis of the spleen, a condition not previously reported in CES, and its significance was discussed.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community mbp alopecia areata or vitamin deficiency

      in Chat 4 months ago
      A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

      community Olumiant alternative for Alopecia Areata?

      in Treatment  1 upvotes 1 year ago
      A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.

    Related Research

    1 / 1 results